Vera Therapeutics Grants 28,800 Options and 14,150 RSUs at $31.26
VERA•Vera Therapeutics granted inducement awards of 28,800 stock options and 14,150 restricted stock units to ten new employees under its 2024 Inducement Plan with an exercise price of $31.26 per share. These equity grants vest over four years with 25% vesting after one year and monthly thereafter.
1. Grant Details
On June 2, 2026, Vera Therapeutics’ Compensation Committee approved inducement awards under Nasdaq Listing Rule 5635(c)(4) comprising 28,800 non-qualified stock options and 14,150 restricted stock units granted to ten newly hired employees under the 2024 Inducement Plan.
2. Vesting and Exercise Terms
Each stock option carries a $31.26 exercise price and vests 25% after one year, followed by monthly vesting over the next 36 months. The RSUs vest 25% on each anniversary of either May 20 or August 20, 2026, depending on the employee start date, over four years.
